The Drug Delivery Innovation Center (DDIC) is pleased to welcome Janssen Pharmaceutica N.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, as a new member. “We are pleased to have Janssen join the DDIC, which will significantly strengthen our industrial backbone that forms the base of our consortium,” said Dr. Werner Hoheisel, Operations Director of the DDIC.

For more information, please refer to this link.

The DDIC was founded in 2017 by the companies Bayer AG, LB Bohle GmbH, Merck KGaA (all Germany) and UCB S.A (Belgium), together with the university partners TU Dortmund and HHU Düsseldorf. INVITE GmbH is leading the consortium. The DDIC fosters international, multi-disciplinary networks in the research area of drug delivery and manufacturing, it promotes pharmaceutical science in close collaboration with academia and pharmaceutical industry along the value chain.